Exagen Inc (XGN): Expected earnings per share growth for next year

Graphic logo of Exagen Inc. (XGN)

Exagen Inc. central laboratories ensure high throughput through the calibration of automated processors. Current expectations for the eps n+1 growth rate confirm this efficiency, with the level sitting around 24.10. Supply chain reliability is guaranteed by the express delivery of biomaterials, while an academic approach and rising salaries enable the retention of leading specialists in the field of autoimmune pathology diagnostics.

XGN: Exagen Inc Earnings growth forecast for next year 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Exagen Diagnostics (XGN)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:Exagen Inc
Finished products of Exagen Inc

This indicator measures the expected earnings per share (EPS) dynamics, determining the future investment attractiveness and solvency of the issuer. Analyzing the one-year forward EPS growth rate allows for an assessment of the analysts' consensus forecast regarding the scaling pace of net income. Calculated levels are based on projected revenue minus operating expenses and tax liabilities. For Exagen Inc. (XGN), these expectations are supported by the inclusion of their tests in systemic lupus erythematosus diagnostic protocols.

Competitor analysis for Exagen Inc.

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Net earnings per share growth forecast for next year Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Expected net earnings per share growth next year|MDXH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Insight Molecular|TRIB (Trinity Biotech) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year PRPH|Earnings growth forecast for next year AIMD|Projected earnings per share increase next year CODX|Net earnings per share growth forecast for next year Heart Test Laboratories HSCS|BMRA: Projected earnings per share growth rate for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year